๐ ๐๐๐ฌ๐ฎ๐ฅ๐ญ๐ฌ
โข EPS: $6.03 (Est. $5.71) โ
โข Revenue: $11.99B (Est. $11.70B) โ
โข Organic revenue growth: 5%
โข Adjusted operating margin: 22.8%, +90 bps YoY
โข GAAP operating income: $2.09B, +14% YoY
โ
๐ฏ ๐๐ฎ๐ข๐๐๐ง๐๐
โข Updated FY2026 guidance will be provided during the earnings conference call.
โ
๐ ๐๐๐ฒ ๐๐๐ค๐๐๐ฐ๐๐ฒ๐ฌ
โข Revenue increased 10% YoY, supported by 5% organic growth as customer activity strengthened across end markets.
โข Launched multiple next-generation mass spectrometry and molecular biology platforms, expanding its AI-enabled life sciences portfolio.
โข Repurchased $1.0B of stock during the quarter and announced the divestiture of its microbiology business.
โ
๐ฌ ๐๐๐ง๐๐ ๐๐ฆ๐๐ง๐ญ ๐๐จ๐ฆ๐ฆ๐๐ง๐ญ๐๐ซ๐ฒ
CEO Marc Casper said Thermo Fisher delivered outstanding execution as end markets continued to strengthen. He highlighted continued share gains, expanding customer partnerships and confidence that the company is well positioned to deliver a strong 2026.